Need help?

Specialty Pharmaceuticals Company Investment Opportunity in Nieuwegein, Netherlands

Vertically integrated firm that will be able to produce Pharma grade API's from own cannabinoids.
This Business is on a Premium Plan
Established 1-5 year(s)
Employees 10 - 50
Legal Entity S Corporation
Reported Sales Nil
Run Rate Sales Nil
EBITDA Margin Nil
Industries Specialty Pharmaceuticals
Locations  Athens + 1 more
Local Time 2:24 PM Europe / Malta
Listed By Business Owner / Director
Status Active
Overall Rating
Seeking Investment
USD 3.7 million for 30.0% stake (Native Currency: EUR 3,500,000)
Reason: We are at a starting stage and need finances to start the construction.
Includes physical assets worth USD 1.6 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview

The facility will have a growing/extraction/distillation/R&D laboratory in order to follow the entire stage of production from mother plant till crystallized form of cannabinoid. With further R&D on lesser known cannabinoids for finding additional uses and health benefits.

Later on we will be focusing on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with generic medicine and potentially edibles, but that will be decided by the market needs.

We have received installation licence for such end products and as the project progresses we will be adding new products to the list:

-Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption;

-Hemp oil in drops for oral consumption > 0.2% THC;

-Hemp oil for sublingual oral consumption (spray) > 0.2% THC;

-Soft cannabis capsules for oral consumption > 0.2% THC;

-Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption.

At the moment we have:

License and permits;

Architectural and engineering plans;

Purchase offers from equipment suppliers;

All described production processes and laboratories;

Long-term land lease for 30+ years with an option to purchase it;

The entire legal structure of the holding;

Verification of processes and architectural solutions under EU GACP & EU GMP standards.

Currently applying for the State Subsidy that cover up to 60% of Capex costs of the project + with an option for fixed corporate Tax for 12 years.

Overall the production facility is projected to grow 6.5+ tons of dried biomaterial on a single tier growing table with ability of scaling.

The EU GMP Laboratory is projected to produce 2.5+ tons of fine oil with an option of scaling by putting second processing line.

Additionally the project is built in mind with an option for a secondary stage expansion through the built of additional production site on the neighboring land.

Products & Services Overview

- Medical flower.

- Pharma grade extracted oils.

- Pharma grade separate cannabinoids.

- Waxes.

- Terpenes.

- Combined API.

Assets Overview

License and permits;

Architectural and engineering plans;

Purchase offers from equipment suppliers;

All described production processes and laboratories;

Long-term land lease for 30+ years with an option to purchase it;

The entire legal structure of the holding;

Three corporate bank accounts in Belgium, Portugal, Greece;

Verification of processes and architectural solutions under EU GACP & EU GMP standards;

Compiling file for the Government Subsidy Program (could cover up to 60% of the Capex costs).

Facilities Overview

The facility will have a combined area of 6,500 square meters.

The production facility is single floor with 4.950 square meters of total area with 2150 sq meters of flowering zone.

The office is 2 floor building with usable roof terrace.

The R&D Lab is 193 square meters.

Long-term land lease for 30+ years with an option to purchase it.

Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

3 Investors contacted this Business this month.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more